Showing results (141-150 of 161) with videos related to

Sort By:
Pageof 17
Therapeutic Drug Monitoring|October 10, 2001
Once-daily versus multiple-daily gentamicin in infants and childrenE V Uijtendaal, C M Rademaker, A F Schobben, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2006
Relationship between cisplatin administration and the development of ototoxicityJeany M Rademaker-Lakhai, Mirjam Crul, Lot Zuur, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2014
Younger Dryas deglaciation of Scotland driven by warming summersGordon R M Bromley, Aaron E Putnam, Kurt M Rademaker, et al.
Cancer Chemotherapy and Pharmacology|September 22, 2006
Metabolism of trabectedin (ET-743, Yondelis) in patients with advanced cancerJan H Beumer, Jeany M Rademaker-Lakhai, Hilde Rosing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumorsJeany M Rademaker-Lakhai, Catherine Terret, Stephen B Howell, et al.
European Journal of Human Genetics : EJHG|April 1, 2004
Linkage disequilibrium in young genetically isolated Dutch populationYurii S Aulchenko, Peter Heutink, Ian Mackay, et al.
Breast Cancer Research and Treatment|November 30, 2019
The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancerAnouk K M Claessens, Reinier Timman, Jan J Busschbach, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 10, 2006
Revisiting late loss and neointimal volumetric measurements in a drug-eluting stent trial: analysis from the SPIRIT FIRST trialKeiichi Tsuchida, Héctor M García-García, Andrew T L Ong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Phase I clinical and pharmacokinetic study of kahalalide F in patients with advanced androgen refractory prostate cancerJeany M Rademaker-Lakhai, Simon Horenblas, Willem Meinhardt, et al.
Pageof 17